- Home
- ENPH vs DGX Comparison
ENPH vs DGX Comparison
Compare ENPH & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENPH
- DGX
- Stock Information
- Founded
- ENPH 2006
- DGX 1967
- Country
- ENPH United States
- DGX United States
- Employees
- ENPH N/A
- DGX N/A
- Industry
- ENPH Semiconductors
- DGX Medical Specialities
- Sector
- ENPH Technology
- DGX Health Care
- Exchange
- ENPH Nasdaq
- DGX Nasdaq
- Market Cap
- ENPH 15.1B
- DGX 17.5B
- IPO Year
- ENPH 2012
- DGX 1996
- Fundamental
- Price
- ENPH $66.15
- DGX $163.58
- Analyst Decision
- ENPH Buy
- DGX Buy
- Analyst Count
- ENPH 31
- DGX 13
- Target Price
- ENPH $101.17
- DGX $163.38
- AVG Volume (30 Days)
- ENPH 6.5M
- DGX 859.5K
- Earning Date
- ENPH 10-22-2024
- DGX 10-22-2024
- Dividend Yield
- ENPH N/A
- DGX 1.83%
- EPS Growth
- ENPH N/A
- DGX 11.56
- EPS
- ENPH 0.44
- DGX 7.44
- Revenue
- ENPH $1,250,240,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- ENPH N/A
- DGX $7.33
- Revenue Next Year
- ENPH $31.47
- DGX $8.69
- P/E Ratio
- ENPH $152.37
- DGX $22.00
- Revenue Growth
- ENPH N/A
- DGX 2.60
- 52 Week Low
- ENPH $58.33
- DGX $123.04
- 52 Week High
- ENPH $141.63
- DGX $165.04
- Technical
- Relative Strength Index (RSI)
- ENPH 32.98
- DGX 64.77
- Support Level
- ENPH $59.71
- DGX $158.52
- Resistance Level
- ENPH $65.55
- DGX $162.88
- Average True Range (ATR)
- ENPH 4.11
- DGX 3.09
- MACD
- ENPH 0.46
- DGX 0.43
- Stochastic Oscillator
- ENPH 15.28
- DGX 88.75
About ENPH Enphase Energy Inc.
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.